Effects of factors on disease-free survival
Parameters . | No. of patients . | No. of relapses . | Univariate analysis . | |
---|---|---|---|---|
HR (95%CI) . | P* . | |||
Sex | ||||
Female | 100 | 16 | 1 | |
Male | 75 | 26 | 1.4 (0.7-2.7) | .29 |
Age, years | ||||
15-50 | 98 | 24 | 1 | |
50-70 | 77 | 18 | 0.9 (0.5-1.7) | .75 |
Leukocyte count, × 109/L | ||||
Less than 10.0 | 138 | 29 | 1 | |
10.0 or higher | 37 | 13 | 1.7 (0.9-3.5) | .12 |
Platelet count, × 109/L | ||||
Less than 40 | 112 | 25 | 1 | |
40 or higher | 63 | 17 | 1.4 (0.7-2.6) | .32 |
Induction therapy | ||||
Group A | 58 | 10 | 1 | |
Group AD | 33 | 6 | 1.0 (0.3-2.9) | .97 |
Group B, BD | 45 | 12 | 1.8 (0.8-4.1) | .17 |
Group C | 39 | 14 | 2.3 (1.0-5.3) | .05 |
Maintenance chemotherapy | ||||
No maintenance | 86 | 17 | 1 | |
Maintenance | 89 | 25 | 1.5 (0.8-2.8) | .20 |
Parameters . | No. of patients . | No. of relapses . | Univariate analysis . | |
---|---|---|---|---|
HR (95%CI) . | P* . | |||
Sex | ||||
Female | 100 | 16 | 1 | |
Male | 75 | 26 | 1.4 (0.7-2.7) | .29 |
Age, years | ||||
15-50 | 98 | 24 | 1 | |
50-70 | 77 | 18 | 0.9 (0.5-1.7) | .75 |
Leukocyte count, × 109/L | ||||
Less than 10.0 | 138 | 29 | 1 | |
10.0 or higher | 37 | 13 | 1.7 (0.9-3.5) | .12 |
Platelet count, × 109/L | ||||
Less than 40 | 112 | 25 | 1 | |
40 or higher | 63 | 17 | 1.4 (0.7-2.6) | .32 |
Induction therapy | ||||
Group A | 58 | 10 | 1 | |
Group AD | 33 | 6 | 1.0 (0.3-2.9) | .97 |
Group B, BD | 45 | 12 | 1.8 (0.8-4.1) | .17 |
Group C | 39 | 14 | 2.3 (1.0-5.3) | .05 |
Maintenance chemotherapy | ||||
No maintenance | 86 | 17 | 1 | |
Maintenance | 89 | 25 | 1.5 (0.8-2.8) | .20 |
Factors affected on disease-free survival were analyzed by the Cox hazard regression model.